SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 574.30 |
| Enterprise Value ($M) | 901.62 |
| Book Value ($M) | -6.75 |
| Book Value / Share | -0.12 |
| Price / Book | -85.06 |
| NCAV ($M) | -173.00 |
| NCAV / Share | -3.20 |
| Price / NCAV | -3.32 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.48 |
| Return on Assets (ROA) | -0.31 |
| Return on Equity (ROE) | -1.63 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.74 |
| Current Ratio | 9.74 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 390.29 |
| Assets | 556.54 |
| Liabilities | 563.29 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 27.12 |
| Operating Income | -182.07 |
| Net Income | -239.56 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -182.73 |
| Cash from Investing | 162.97 |
| Cash from Financing | -59.49 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vestal Point Capital, LP | 6.20 | -36.32 | |
| 13G | EcoR1 Capital, LLC | 7.50 | ||
| 13G/A | Nantahala Capital Management, LLC | 6.12 | -5.57 | |
| 13G/A | Bristol Myers Squibb Co | 4.90 | 0.00 | |
| 13G/A | Boxer Capital Management, LLC | 4.60 | ||
| 13G/A | State Street Corp | 0.40 | -94.97 | |
| 13G | Boxer Capital, LLC | 5.10 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 301,151 | 1,517,790 | 19.84 | |
| 475,599 | 1,769,989 | 26.87 | |
| 477,061 | 1,884,389 | 25.32 | |
| 921,077 | 3,707,827 | 24.84 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PYXS – Pyxis Oncology, Inc. | QDEL – QuidelOrtho Corporation |
| QNCX – Quince Therapeutics, Inc. | RARE – Ultragenyx Pharmaceutical Inc. |
| RDUS – Radius Recycling, Inc. |
Financial data and stock pages provided by
Fintel.io